 |
|
|
|
|
Oregon Life Science Industry Directory
Target your advertising by state, region or nationwide for the same low rate
Banner Advertising | Event Advertising
UbiVac, LLC
| UbiVac, LLC
18183 SW Boones Ferry Rd.
Portland, OR 972224 |  |
| | | | Phone: | (503) 215-3769 | | Year Established: | 2005 | | Main Contact: | Bernard A. Fox, PhD, President & CEO | | | | Other Contacts: | Traci L. Hilton, Ph.D., VP, Vaccine Development
Bernard A. Fox III, MBA, COO
Steve Buhaly, CFO
Hong-Ming Hu, Ph.D., Founder & CSO
| | | | Company Description | UbiVac is a clinical stage immuno-oncology company that offers a pipeline of groundbreaking immunotherapies in preclinical and clinical trials.
UbiVac’s lead product, DPV-001 (DRibble), is a first in class DC-targeted complex vaccine/combination immunotherapy that is “off-the-shelf” and in a National Cancer Institute-supported Phase II clinical trial for the adjuvant treatment of non-small cell lung cancer (NSCLC). Results of this clinical trial document that DPV-001 induces and/or boosts the immune response in every patient who received the vaccine. | |
|
|
|
|
|
|
|
